At the 4th Annual World Anti-Microbial Resistance Congress, over 400 stakeholders will gather in Washington D.C. to discuss critical challenges and opportunities to advance antibiotic and diagnostics development, improve antimicrobial stewardship practice and incentivize funding and partnering to bring innovation to patients and the healthcare system in need.  Discussions will be addressing 4 key areas: Antibiotic R&D, Diagnostics, Antimicrobial Stewardship, and Innovation Showcase.

Presentations by Tyler Merkeley of BARDA and Dr. Barry Eisenstein, Chair of the CARB-X Advisory Board.